Dayangac-Erden, D. Et Al. 2009. Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy. CHEMICAL BIOLOGY & DRUG DESIGN , vol.73, no.3 , 355-364.

Dayangac-Erden, D., Bora, G., Ayhan, P., Kocaefe, C., DALKARA, S., Yelekci, K., ... DEMİR, A. G.(2009). Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy. CHEMICAL BIOLOGY & DRUG DESIGN , vol.73, no.3, 355-364.

Dayangac-Erden, DİDEM Et Al. "Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy," CHEMICAL BIOLOGY & DRUG DESIGN , vol.73, no.3, 355-364, 2009

Dayangac-Erden, DİDEM D. Et Al. "Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy." CHEMICAL BIOLOGY & DRUG DESIGN , vol.73, no.3, pp.355-364, 2009

Dayangac-Erden, D. Et Al. (2009) . "Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy." CHEMICAL BIOLOGY & DRUG DESIGN , vol.73, no.3, pp.355-364.

@article{article, author={DİDEM DAYANGAÇ ERDEN Et Al. }, title={Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy}, journal={CHEMICAL BIOLOGY & DRUG DESIGN}, year=2009, pages={355-364} }